Smart Money Alert

Dr. Lal Path Labs Ltd

DecreasedQuarterly

LALPATHLABHealthcareMarket Cap₹34K Cr

Stake

4.05% → 3.91%

HDFC Mutual Fund

Mutual Fund

The move

HDFC Mutual Fund decreased its stake in Dr. Lal Path Labs from 4.05% to 3.91%, selling 233,290 shares. At a share price of ₹1699.00, the sale was worth approximately ₹39.64 Cr.

About Dr. Lal Path Labs Ltd

Visit stock

A leading diagnostic services provider in India, Dr. Lal PathLabs operates an integrated nationwide network delivering laboratory tests and comprehensive healthcare services. The company serves individual patients, hospitals, healthcare providers, and corporate clients through core diagnostic testing, disease diagnosis, prevention, monitoring, and treatment support. Its distinctive strength lies in combining consumer accessibility with a broad range of diagnostic capabilities and related health services across the country.

About HDFC Mutual Fund

Visit investor

One of India's oldest and most trusted AMCs with over Rs 7.5 lakh crore in AUM. Founded in 1999 as a joint venture between HDFC Bank and Standard Life. MD and CEO Navneet Munot, formerly CIO of SBI MF, has reinforced the quality and compounding philosophy across equity schemes. HDFC Flexi Cap Fund and HDFC Mid-Cap Opportunities Fund are among the largest actively managed equity schemes in India.

Get the next move the moment it happens.

Follow HDFC Mutual Fund and Dr. Lal Path Labs Ltd on WhaleWatch, alongside 300+ top investors, funds and FPIs. The newest moves are waiting for you inside.

Explore

Dr. Lal Path Labs Ltd shareholders HDFC Mutual Fund's portfolio All investors All stocks

🤖 We track their every move, post, interview and article. Obsessively.

⚡ Every move reaches your feed in minutes, while it still carries an edge

📊 Stake changes, bulk deals and insider trades, all tracked in one place

📰 A two-minute morning brief, so you start the day already ahead

More moves in Dr. Lal Path Labs Ltd

Tata Mutual FundDecreased

Tata Mutual Fund sold 5,66,848 shares of Dr. Lal Path Labs Ltd, reducing its stake from 1.75% to 1.41% for approximately ₹108.21 Cr at ₹1,909 apiece.

11 Sept 2026

SBI Mutual FundExited

SBI Mutual Fund is no longer on Dr. Lal Path Labs Ltd's list of disclosed shareholders, after its last reported stake of 1.65 percent, indicating either a complete sale or a reduction below the 1 percent disclosure threshold.